DOCS: Bull Flag detected on 21 Jul 2026

Doximity is forming a bull flag pattern following recent strength, with shares at $21.73 sitting between key support at $20.90 and resistance at $23.57. The structure score of 14.5/15 reflects a well-defined consolidation, though breakout strength at 10.4/13 suggests caution—the flag lacks decisive volume confirmation. Volume ratio of 1.08x is adequate but not exceptional. RSI at 51.31 indicates neutral momentum, neither overbought nor oversold. The 73.53% win probability and 75.9 overall score indicate a statistically favorable setup, though near-term weakness (-2.51% last week) shows price hasn't yet committed to the upside.

Doximity reported Q3 2026 revenues of $185.1 million, up 10% year-over-year, with net income margin of 33% and adjusted EBITDA margin of 60%. For full fiscal 2026, revenues reached $644.9 million (up 13% YoY) and nearly half of active prescribers used clinical AI in Q4, while prompts per user nearly doubled. Net revenue retention stands at 118% on trailing 12-month basis, signaling strong upsell dynamics. However, management flagged uncertainty around budget discussions for calendar 2026 that could impact future revenue growth, and the company faces ongoing litigation with OpenEvidence. Stock is down 71.6% from 52-week highs despite solid fundamentals, suggesting market repricing of valuation or sector rotation risk.

A successful bull flag breakout would target $22.45 on the conservative measure, representing approximately 3.3% upside from current price—modest but measurable. Volume confirmation above 23.57 resistance is critical; breakout should occur on above-average volume (expect 3.5M+ shares). Invalidation occurs at support of $20.90; a close below that level signals pattern failure. With 73.53% historical win probability, breakouts tend to follow through, though recent 3-month underperformance (-12.06%) and sector headwinds (bearish regime at -0.34) warrant disciplined entry. Measured move suggests limited room to run but reliable odds.

Budget uncertainty for 2026 and a smoother upsell cycle mean Q3 growth may not step up as in previous years, pressuring revenue trajectory. OpenEvidence litigation poses ongoing risk. Sector regime is bearish (-0.34), dragging Technology/EDP Services stocks lower. Stock beta of 0.1 is extremely low—unusual for a SaaS company—and may reflect illiquidity or depressed trading. The 71.6% gap below 52-week highs indicates significant capital destruction; recent earnings beat (+15% EPS surprise) failed to sustain momentum, suggesting investor skepticism on valuation or execution. Volatility at 4.56% ATR is moderate; unexpected healthcare policy shifts or pharma budget cuts could trigger sharp reversals.

We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.